Advanced
  Home Compare Reports

Comparison with Similar Reports

Hearing Aids Market by Product Type [Aids (Receiver,Behind the Ear, In the Canal, In the Ear Aids), Implants (Cochlear, Bone-anchored)], Type of Heari...

Publisher:        MarketsandMarkets

# of Pages:        230

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.2 MARKETS COVERED 33
FIGURE 1 HEARING AIDS MARKET SEGMENTATION 33
1.2.3 YEARS CONSIDERED FOR THE STUDY 33
1.3 CURRENCY 34
1.4 LIMITATIONS 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.2 RESEARCH APPROACH 36
FIGURE 2 HEARING AIDS MARKET: RESEARCH DESIGN 36
2.2.1 SECONDARY DATA 36
2.2.1.1 Key data from secondary sources 37
2.2.2 PRIMARY DATA 38
2.2.2.1 Primary sources 38
2.2.2.2 Key data from primary sources 39
2.2.2.3 Key industry insights 39
2.2.2.4 Breakdown of primary interviews 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HEARING AIDS MARKET) 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 40
2.3 MARKET SIZE ESTIMATION 40
2.3.1 BOTTOM-UP APPROACH 41
2.3.1.1 Approach 1: Company revenue estimation approach 41
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 41
2.3.1.2 Approach 2: Market estimation from the parent market 41
FIGURE 6 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET 41
2.3.1.3 Approach 3: Presentations of companies and primary interviews 42
2.3.1.4 Growth rate assumptions 42
2.3.1.5 CAGR projections 42
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
 
2.3.2 TOP-DOWN APPROACH 43
FIGURE 8 HEARING AIDS MARKET: TOP-DOWN APPROACH 43
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 LIMITATIONS 45
2.7 RISK ASSESSMENT 46
TABLE 1 RISKS ASSESSMENT 46
2.8 COVID-19 HEALTH ASSESSMENT 46
2.9 COVID-19 ECONOMIC ASSESSMENT 46
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 47
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE HEARING AIDS MARKET 48
3 EXECUTIVE SUMMARY 49
FIGURE 11 HEARING AIDS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 49
FIGURE 12 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2021 VS. 2026 (USD MILLION) 50
FIGURE 13 HEARING AIDS MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 14 HEARING AIDS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 51
4 PREMIUM INSIGHTS 52
4.1 HEARING AIDS MARKET OVERVIEW 52
FIGURE 15 RISING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET GROWTH 52
4.2 HEARING AIDS MARKET SHARE, BY PRODUCT, 2021 VS. 2026 52
FIGURE 16 HEARING AID DEVICES SEGMENT WILL CONTINUE TO DOMINATE
THE MARKET IN 2026 52
4.3 HEARING AIDS MARKET SHARE, BY TYPE OF HEARING LOSS, 2021 VS. 2026 53
FIGURE 17 SENSORINEURAL HEARING LOSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 53
4.4 HEARING AIDS MARKET SHARE, BY PATIENT TYPE, 2021 VS. 2026 53
FIGURE 18 ADULT PATIENTS SEGMENT TO CONTINUE TO DOMINATE
THE MARKET IN 2026 53
4.5 HEARING AIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE HEARING AIDS MARKET DURING THE FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 20 HEARING AIDS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 55
5.2.1.1 Growing prevalence of hearing loss 55
FIGURE 21 ESTIMATED NUMBER OF PEOPLE WITH DISABLING
HEARING LOSS, GLOBALLY 56
FIGURE 22 PREVALENCE OF HEARING LOSS, BY REGION, 2019 56
5.2.1.1.1 Growth in the geriatric population 57
FIGURE 23 SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019) 57
5.2.1.2 Technological advancements in hearing aids 57
5.2.1.3 Increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss 58
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of hearing aids 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Emerging markets offer lucrative opportunities 59
5.2.4 CHALLENGES 59
5.2.4.1 Shortage of trained professionals 59
5.3 EPIDEMIOLOGY DATA ON HEARING LOSS AND THE ADOPTION OF
HEARING AID DEVICES 60
TABLE 2 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP 60
TABLE 3 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP (10-YEAR RANGE) 60
TABLE 4 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP 61
5.4 IMPACT OF COVID-19 ON THE HEARING AIDS MARKET 61
5.5 CASE STUDY ANALYSIS 62
5.5.1 CASE STUDY 1: FINDING A NEW WAY TO LISTEN TO CUSTOMERS 62
5.5.2 CASE STUDY 2: EFFECTIVE SERVICE DELIVERY MODELS AND REGULATIONS CAN IMPROVE ACCESS TO HEARING AIDS 62
5.5.3 CASE STUDY 3: OVER-THE-COUNTER HEARING AID DELIVERY CAN IMPROVE ACCESSIBILITY AND AFFORDABILITY 63
5.6 PESSIMISTIC AND OPTIMISTIC SCENARIOS 63
5.6.1 HEARING AIDS MARKET 63
FIGURE 24 PESSIMISTIC SCENARIO 63
FIGURE 25 OPTIMISTIC SCENARIO 64
5.7 PRICING ANALYSIS 64
TABLE 5 PRICE OF HEARING AIDS (2021) 64
5.8 PATENT ANALYSIS 65
5.8.1 PATENT ANALYSIS OF COCHLEAR IMPLANTS 65
5.9 TRADE ANALYSIS 65
5.9.1 TRADE ANALYSIS FOR HEARING AIDS 65
TABLE 6 IMPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION) 65
TABLE 7 EXPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION) 66
5.10 VALUE CHAIN ANALYSIS 66
FIGURE 26 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 66
5.10.1 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR 67
TABLE 8 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR 67
5.11 SUPPLY CHAIN ANALYSIS 67
FIGURE 27 HEARING AIDS MARKET: SUPPLY CHAIN ANALYSIS 68
5.12 ECOSYSTEM ANALYSIS OF THE HEARING AIDS MARKET 69
FIGURE 28 HEARING AIDS MARKET: ECOSYSTEM ANALYSIS 69
5.12.1 ROLE IN ECOSYSTEM 69
5.13 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 9 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.13.1 THREAT OF NEW ENTRANTS 70
5.13.2 THREAT OF SUBSTITUTES 70
5.13.3 BARGAINING POWER OF BUYERS 70
5.13.4 BARGAINING POWER OF SUPPLIERS 70
5.13.5 DEGREE OF COMPETITION 71
5.14 REGULATORY LANDSCAPE 71
5.14.1 NORTH AMERICA 71
5.14.1.1 US 71
5.14.1.2 Canada 71
5.14.2 EUROPE 71
5.14.3 ASIA PACIFIC 71
5.14.3.1 Japan 71
5.14.3.2 India 72
5.14.4 LATIN AMERICA 72
5.14.4.1 Brazil 72
5.14.4.2 Mexico 72
5.14.5 MIDDLE EAST 72
5.15 TECHNOLOGY ANALYSIS 73
5.16 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS 74
5.16.1 REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 74
5.16.2 REVENUE SHIFT FOR THE HEARING AIDS MARKET 74
6 HEARING AIDS MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 10 HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 76
TABLE 11 HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 76
6.2 HEARING AID DEVICES 76
TABLE 12 KEY PRODUCTS IN THE HEARING AID DEVICES MARKET 77
TABLE 13 HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION) 78
TABLE 14 HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION) 78
TABLE 15 HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (MILLION UNITS) 79
TABLE 16 HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (MILLION UNITS) 79
TABLE 17 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS) 80
TABLE 18 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS) 80
TABLE 19 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS) 80
TABLE 20 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS) 81
TABLE 21 APAC: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS) 81
TABLE 22 APAC: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS) 82
TABLE 23 HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 82
TABLE 24 HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 83
TABLE 25 HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (MILLION UNITS) 83
TABLE 26 HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (MILLION UNITS) 83
6.2.1 RECEIVER-IN-THE-EAR HEARING AIDS 84
6.2.1.1 RITE hearing aid devices are suitable for the treatment of
mild-to-severe hearing loss 84
TABLE 27 KEY PRODUCTS IN THE RECEIVER-IN-THE-EAR HEARING AIDS MARKET 84
TABLE 28 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2016–2019 (USD MILLION) 85
TABLE 29 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2020–2026 (USD MILLION) 85
TABLE 30 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 86
TABLE 31 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 86
TABLE 32 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET,
BY COUNTRY, 2016–2019 (USD MILLION) 87
TABLE 33 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET,
BY COUNTRY, 2020–2026 (USD MILLION) 87
TABLE 34 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 87
TABLE 35 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 88
6.2.2 BEHIND-THE-EAR HEARING AIDS 88
6.2.2.1 Low cost of BTE devices to support the market growth 88
TABLE 36 KEY PRODUCTS IN THE BEHIND-THE-EAR HEARING AIDS MARKET 89
TABLE 37 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION,
2016–2019 (USD MILLION) 89
TABLE 38 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION,
2020–2026 (USD MILLION) 90
TABLE 39 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 90
TABLE 40 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 91
TABLE 41 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 91
TABLE 42 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 91
TABLE 43 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 92
TABLE 44 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 92
6.2.3 CANAL HEARING AIDS 93
6.2.3.1 Technological advancements in canal hearing aids to
propel market growth 93
TABLE 45 KEY PRODUCTS IN THE CANAL HEARING AIDS MARKET 93
TABLE 46 CANAL HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION) 94
TABLE 47 CANAL HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION) 94
TABLE 48 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 95
TABLE 49 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 95
TABLE 50 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 95
TABLE 51 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 96
TABLE 52 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 96
TABLE 53 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 96
6.2.4 IN-THE-EAR HEARING AIDS 97
6.2.4.1 Longer battery life of ITE hearing devices to support
the market growth 97
TABLE 54 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION) 97
TABLE 55 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION) 97
TABLE 56 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 98
TABLE 57 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 98
TABLE 58 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 99
TABLE 59 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 99
TABLE 60 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 99
TABLE 61 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 100
6.2.5 OTHER HEARING AID DEVICES 100
TABLE 62 OTHER HEARING AID DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 100
TABLE 63 OTHER HEARING AID DEVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 101
TABLE 64 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 101
TABLE 65 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 102
TABLE 66 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 102
TABLE 67 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 102
TABLE 68 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 103
TABLE 69 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 103
6.3 HEARING IMPLANTS 103
TABLE 70 HEARING IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION) 104
TABLE 71 HEARING IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION) 104
TABLE 72 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 104
TABLE 73 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 105
TABLE 74 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 105
TABLE 75 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 105
TABLE 76 APAC: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 106
TABLE 77 APAC: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 106
TABLE 78 HEARING IMPLANTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 106
TABLE 79 HEARING IMPLANTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 107
6.3.1 COCHLEAR IMPLANTS 107
6.3.1.1 Cochlear implants segment to dominate the hearing implants market 107
TABLE 80 KEY PRODUCTS IN THE COCHLEAR IMPLANTS MARKET 108
TABLE 81 COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 82 COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION) 108
TABLE 83 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 109
TABLE 84 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 109
TABLE 85 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 109
TABLE 86 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 110
TABLE 87 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 110
TABLE 88 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 110
6.3.2 BONE-ANCHORED SYSTEMS 111
6.3.2.1 BAHA implants are gaining traction among children and adults with single-sided deafness and conductive hearing loss 111
TABLE 89 BONE-ANCHORED SYSTEMS MARKET, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 90 BONE-ANCHORED SYSTEMS MARKET, BY REGION,
2020–2026 (USD MILLION) 112
TABLE 91 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 112
TABLE 92 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 113
TABLE 93 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 113
TABLE 94 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 113
TABLE 95 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 114
TABLE 96 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 114
7 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS 115
7.1 INTRODUCTION 116
TABLE 97 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 116
TABLE 98 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 116
7.2 SENSORINEURAL HEARING LOSS 116
7.2.1 GROWING GERIATRIC PATIENT POOL TO SUPPORT THE GROWTH OF
THIS MARKET SEGMENT 116
7.2.1.1 Primary notes 117
7.2.1.1.1 Key industry insights 117
TABLE 99 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2016–2019 (USD MILLION) 118
TABLE 100 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2020–2026 (USD MILLION) 118
7.3 CONDUCTIVE HEARING LOSS 118
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEARING AIDS AND INCREASING PRODUCT APPROVALS TO PROPEL MARKET GROWTH 118
TABLE 101 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2016–2019 (USD MILLION) 119
TABLE 102 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2020–2026 (USD MILLION) 119
8 HEARING AIDS MARKET, BY PATIENT TYPE 120
8.1 INTRODUCTION 121
TABLE 103 HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 121
TABLE 104 HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 121
8.2 ADULTS 121
8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS A KEY SEGMENT OF THE OVERALL PATIENT POOL 121
8.2.1.1 Primary notes 122
8.2.1.1.1 Key industry insights 122
TABLE 105 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2016–2019 (USD MILLION) 123
TABLE 106 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2020–2026 (USD MILLION) 123
8.3 PEDIATRICS 123
8.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF
THIS MARKET SEGMENT 123
TABLE 107 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2016–2019 (USD MILLION) 124
TABLE 108 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2020–2026 (USD MILLION) 125
9 HEARING AIDS MARKET, BY REGION 126
9.1 INTRODUCTION 127
TABLE 109 HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION) 127
TABLE 110 HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION) 127
9.2 EUROPE 128
FIGURE 29 EUROPE: HEARING AIDS MARKET SNAPSHOT 128
TABLE 111 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 129
TABLE 112 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 129
TABLE 113 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 129
TABLE 114 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 130
TABLE 115 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 130
TABLE 116 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 130
9.2.1 GERMANY 131
9.2.1.1 Growth in healthcare expenditure in Germany to drive the demand for technologically advanced hearing aids 131
FIGURE 30 PREVALENCE OF HEARING LOSS IN GERMANY, 2015 VS. 2018 131
FIGURE 31 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN GERMANY, 2012 VS. 2015 VS. 2018 131
TABLE 117 GERMANY: KEY MACROINDICATORS 132
TABLE 118 GERMANY: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 132
TABLE 119 GERMANY: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 133
TABLE 120 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 133
TABLE 121 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 133
TABLE 122 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 134
TABLE 123 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 134
9.2.2 UK 134
9.2.2.1 High and growing prevalence of hearing loss to drive market
growth in the UK 134
TABLE 124 UK: KEY MACROINDICATORS 135
TABLE 125 UK: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 135
TABLE 126 UK: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 136
TABLE 127 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 136
TABLE 128 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 136
TABLE 129 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 137
TABLE 130 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 137
9.2.3 FRANCE 137
9.2.3.1 Rising R&D expenditure in France to drive the market growth 137
FIGURE 32 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN FRANCE, 2012 VS. 2015 VS. 2018 138
TABLE 131 FRANCE: KEY MACROINDICATORS 138
TABLE 132 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 138
TABLE 133 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 139
TABLE 134 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 139
TABLE 135 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 139
TABLE 136 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 140
TABLE 137 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 140
9.2.4 SPAIN 140
9.2.4.1 Increasing life expectancy and growing geriatric population to drive market growth in Spain 140
FIGURE 33 SPAIN: PREVALENCE OF HEARING LOSS IN 2020, BY AGE GROUP 141
TABLE 138 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 141
TABLE 139 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 142
TABLE 140 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 142
TABLE 141 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 142
TABLE 142 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 142
TABLE 143 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 143
9.2.5 ITALY 143
9.2.5.1 Unfavorable reimbursement scenario to restrain market growth in Italy to a certain extent 143
FIGURE 34 PREVALENCE OF HEARING LOSS IN ITALY, 2012 VS. 2015 VS. 2018 143
FIGURE 35 HEARING AIDS ADOPTION RATE IN ITALY, 2012 VS. 2015 VS. 2018 144
TABLE 144 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 144
TABLE 145 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 144
TABLE 146 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 145
TABLE 147 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 145
TABLE 148 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 145
TABLE 149 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 146
9.2.6 REST OF EUROPE 146
TABLE 150 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 146
TABLE 151 ROE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 147
TABLE 152 ROE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 147
TABLE 153 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 147
TABLE 154 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 148
TABLE 155 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 148
TABLE 156 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 148
9.3 NORTH AMERICA 149
TABLE 157 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 149
TABLE 158 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 149
TABLE 159 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 150
TABLE 160 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 150
TABLE 161 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION) 150
TABLE 162 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION) 151
9.3.1 US 151
9.3.1.1 The US dominated the North American hearing aids market in 2020 151
FIGURE 36 NUMBER OF AUDIOLOGISTS IN THE US 152
TABLE 163 US: KEY MACROINDICATORS 153
TABLE 164 US: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 153
TABLE 165 US: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 153
TABLE 166 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 154
TABLE 167 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 154
TABLE 168 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 154
TABLE 169 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 155
9.3.2 CANADA 155
9.3.2.1 Conferences, webinars, and symposia to provide impetus to the market growth 155
TABLE 170 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 156
TABLE 171 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 156
TABLE 172 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 156
TABLE 173 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 157
TABLE 174 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 157
TABLE 175 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 157
9.4 ASIA PACIFIC 158
FIGURE 37 ASIA PACIFIC: HEARING AIDS MARKET SNAPSHOT 159
TABLE 176 APAC: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 160
TABLE 177 APAC: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 160
TABLE 178 APAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 160
TABLE 179 APAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 161
TABLE 180 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 161
TABLE 181 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 161
9.4.1 CHINA 161
9.4.1.1 China dominated the APAC market for hearing aids in 2020 161
TABLE 182 CHINA: KEY MACROINDICATORS 162
TABLE 183 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 162
TABLE 184 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 162
TABLE 185 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 163
TABLE 186 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 163
TABLE 187 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 163
TABLE 188 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 164
9.4.2 INDIA 164
9.4.2.1 Healthcare infrastructure improvements to drive
market growth in India 164
TABLE 189 INDIA: KEY MACROINDICATORS 165
TABLE 190 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 165
TABLE 191 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 165
TABLE 192 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 166
TABLE 193 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 166
TABLE 194 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 166
TABLE 195 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 167
9.4.3 JAPAN 167
9.4.3.1 Rising adoption of hearing aids in the country to
support market growth 167
FIGURE 38 HEARING AIDS ADOPTION RATE IN JAPAN, 2012 VS. 2015 VS. 2018 167
TABLE 196 JAPAN: KEY MACROINDICATORS 168
TABLE 197 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 168
TABLE 198 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 168
TABLE 199 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 169
TABLE 200 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 169
TABLE 201 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 169
TABLE 202 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 170
9.4.4 AUSTRALIA 170
9.4.4.1 Rising geriatric population to drive market growth in Australia 170
FIGURE 39 DISTRIBUTIVE SHARE OF POPULATION IN AUSTRALIA, BY AGE GROUP,
2016 VS. 2019 170
TABLE 203 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 171
TABLE 204 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 171
TABLE 205 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 172
TABLE 206 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 172
TABLE 207 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 172
TABLE 208 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 173
9.4.5 REST OF ASIA PACIFIC 173
FIGURE 40 DISTRIBUTIVE SHARE OF POPULATION IN TAIWAN, BY AGE GROUP,
2016 VS. 2019 174
TABLE 209 ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 174
TABLE 210 ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 175
TABLE 211 ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 175
TABLE 212 ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 175
TABLE 213 ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 176
TABLE 214 ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 176
9.5 LATIN AMERICA 176
9.5.1 INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE
IN THE REGION TO SUPPORT MARKET GROWTH 176
FIGURE 41 NUMBER OF PEOPLE WITH DISABLING HEARING LOSS IN BRAZIL AND MEXICO, 2008 VS. 2018 177
TABLE 215 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 177
TABLE 216 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 178
TABLE 217 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 178
TABLE 218 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 178
TABLE 219 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 179
TABLE 220 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 179
9.6 MIDDLE EAST & AFRICA 179
9.6.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS IN THE REGION TO
DRIVE MARKET GROWTH 179
TABLE 221 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 180
TABLE 222 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 180
TABLE 223 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION) 180
TABLE 224 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION) 181
TABLE 225 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 181
TABLE 226 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 181
10 COMPETITIVE LANDSCAPE 182
10.1 OVERVIEW 182
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 182
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE HEARING AIDS MARKET 183
TABLE 227 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HEARING AIDS MANUFACTURING COMPANIES 183
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 184
FIGURE 42 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN
THE HEARING AIDS MARKET 184
10.4 MARKET SHARE ANALYSIS 185
FIGURE 43 HEARING AIDS MARKET SHARE, BY KEY PLAYER (2020) 185
TABLE 228 HEARING AIDS MARKET: DEGREE OF COMPETITION 185
10.5 COMPANY EVALUATION QUADRANT 186
10.5.1 LIST OF EVALUATED VENDORS 186
10.5.2 STARS 186
10.5.3 EMERGING LEADERS 187
10.5.4 PERVASIVE PLAYERS 187
10.5.5 PARTICIPANTS 187
FIGURE 44 HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 188
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020) 188
10.6.1 PROGRESSIVE COMPANIES 188
10.6.2 STARTING BLOCKS 189
10.6.3 RESPONSIVE COMPANIES 189
10.6.4 DYNAMIC COMPANIES 189
FIGURE 45 HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020 190
10.7 COMPETITIVE BENCHMARKING 190
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS 190
FIGURE 46 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN
THE HEARING AIDS MARKET 190
TABLE 229 PRODUCT FOOTPRINT OF COMPANIES 191
TABLE 230 REGIONAL FOOTPRINT OF COMPANIES 191
10.8 COMPETITIVE SCENARIO 192
10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS 192
TABLE 231 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS 192
10.8.2 DEALS 193
TABLE 232 KEY DEALS 193
11 COMPANY PROFILES 194
11.1 KEY PLAYERS 194
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 SONOVA GROUP 194
TABLE 233 SONOVA GROUP: BUSINESS OVERVIEW 194
FIGURE 47 SONOVA GROUP: COMPANY SNAPSHOT (2020) 195
11.1.2 DEMANT A/S 199
TABLE 234 DEMANT A/S: BUSINESS OVERVIEW 199
FIGURE 48 DEMANT A/S: COMPANY SNAPSHOT (2020) 200
11.1.3 GN STORE NORD A/S 204
TABLE 235 GN STORE NORD A/S: BUSINESS OVERVIEW 204
FIGURE 49 GN STORE NORD A/S: COMPANY SNAPSHOT (2020) 205
11.1.4 COCHLEAR LTD. 208
TABLE 236 COCHLEAR LTD.: BUSINESS OVERVIEW 208
FIGURE 50 COCHLEAR LTD.: COMPANY SNAPSHOT (2020) 208
11.1.5 RION CO., LTD. 211
TABLE 237 RION CO., LTD.: BUSINESS OVERVIEW 211
FIGURE 51 RION CO., LTD.: COMPANY SNAPSHOT (2020) 211
11.1.6 STARKEY 214
TABLE 238 STARKEY: BUSINESS OVERVIEW 214
11.1.7 WS AUDIOLOGY A/S 216
TABLE 239 WS AUDIOLOGY A/S: BUSINESS OVERVIEW 216
11.1.8 NUROTRON BIOTECHNOLOGY CO., LTD. 218
TABLE 240 NUROTRON BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 218
11.1.9 MED-EL 219
TABLE 241 MED-EL: BUSINESS OVERVIEW 219
11.1.10 AUDINA HEARING INSTRUMENTS, INC. 220
TABLE 242 AUDINA HEARING INSTRUMENTS, INC.: BUSINESS OVERVIEW 220
11.1.11 ELKON PVT. LTD. 222
TABLE 243 ELKON PVT. LTD.: BUSINESS OVERVIEW 222
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 223
11.2.1 EARGO, INC. 223
11.2.2 HORENTEK 224
11.2.3 ZOUNDS HEARING INC. 225
11.2.4 SEBOTEK HEARING SYSTEMS, LLC. 225
11.2.5 ARPHI ELECTRONICS PRIVATE LIMITED 226
11.2.6 IN4 TECHNOLOGY CORPORATION 227
11.2.7 BHM-TECH PRODUKTIONSGESELLSCHAFT MBH 227
11.2.8 NANO HEARING AIDS 228
11.2.9 LORECA S.R.O. 229
11.2.10 EARLENS CORPORATION 230
11.2.11 AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD. 230
11.2.12 LIVELY HEARING CORPORATION 230
11.2.13 AUDIFON GMBH & CO. KG 231
11.2.14 FOSHAN VOHOM TECHNOLOGY CO., LTD. 231
12 APPENDIX 232
12.1 DISCUSSION GUIDE 232
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
12.3 AVAILABLE CUSTOMIZATIONS 237
12.4 RELATED REPORTS 237
12.5 AUTHOR DETAILS 238

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127